Report Highlights
The global neuroprosthetics market reached $5.0 billion in 2022, should reach $5.4 billion by 2023 and $8.1 billion by 2028 with a compound annual growth rate (CAGR) of 8.3% during the forecast period of 2023-2028.
Report Includes
- 32 data tables and 49 additional tables
- A comprehensive overview and an up-to-date analysis of the global market for neuroprosthetics
- Analyses of the global market trends, with historical market revenue data (sales figures) for 2022, estimates for 2023, forecasts for 2024 and 2026, and projections of compound annual growth rates (CAGRs) through 2028
- An estimate of the actual market size and a revenue forecast for the global neuroprosthetics market in USD millions, and a corresponding analysis of market share based on product, type of stimulation technology, application and region
- In-depth information (facts and figures) related to the major factors influencing the growth of this market with respect to challenges, upcoming technologies, future prospects and contributions to the overall market
- A discussion of ESG developments in the neuroprosthetics market, along with insight into the importance of ESG, consumer attitudes towards sustainability, an assessment of risks and opportunities, and the ESG practices followed by product manufacturers and other industry participants
- A patent analysis with significant allotments of key patent awarded in neuroprosthetics
- A review of recent mergers and acquisitions (M&A) activity and venture funding
- Identification of leading and emerging companies in the global neuroprosthetics market, and an analysis of the competitive landscape based on recent developments, segmental revenues and operational integration
- Profiles of leading companies
Report Scope
This research study aims to thoroughly assess and analyze the neuroprosthetics market, revenue forecasts and future trends, globally, and to provide strategic recommendations for the success of market participants. The scope of the study is global. Current and projected market forecasts during the forecast period (2023 to 2028) are discussed. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type, application and region from 2023 through 2028.
This report also includes an analysis of leading and emerging competitors in the worldwide neuroprosthetics market. Profiles of leading product manufacturers and emerging players with novel products in development are also analyzed. This report assesses companies poised to introduce products during the forecast period and discusses how these introductions will change the face of the competitive environment.
Report Synopsis
| Report Metrics | Details | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||
| Base year market size | $5.0 billion | ||||||||||||||
| Market size forecast | $8.1 billion | ||||||||||||||
| Growth rate | CAGR of 8.3% for the forecast period of 2023-2028 | ||||||||||||||
| Units considered | $ Millions | ||||||||||||||
| Segments covered | Product Type, Application, Region | ||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, China, Japan, India, Australia, South Korea, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Indonesia, Latin America, Middle East and Africa | ||||||||||||||
| Key Market Drivers |
|
||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
- Favorable demographic trends and increasing prevalence of neurological disorders.
- Technological advancements.
- Support from regulatory agencies.
- Increasing pressure to curtail healthcare costs.
- Robust funding environment for biomedical research.
- Medtronic Plc,
- Abbott Laboratories,
- Boston Scientific Corp., and
- Cochlear Ltd.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Neurostimulation: Technologies and Global Markets
The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).
Neurotech Devices: Global Market Outlook
This report provides an up-to-date analysis of the global market for global neurotech devices market. It offers a comprehensive description and evaluation of the global market for neurotech devices, while the market has been segmented on the basis of product type, end users, and region. Using 2021 as the base year, the report estimates market data for 2022-2027. The report concludes with a particular focus on the vendor landscape.
Electroceuticals: Technologies and Global Markets
The global electroceuticals market should reach $25.5 billion by the end of year 2022 and should reach more than $35.5 billion by year 2027, with a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2022-2027.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More